Evidence map›Paper›PMID 39546570›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Lauren C Radlinski, Andrew W L Rogers, Lalita Bechtold, Hugo L P Masson, Henry Nguyen, Anaïs B Larabi, Connor R Tiffany, Thaynara Parente de Carvalho, Renée M Tsolis, Andreas J Bäumler

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lauren C RadlinskiDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.
Andrew W L RogersDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.
Lalita BechtoldDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.
Hugo L P MassonDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.
Henry NguyenDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.
Anaïs B LarabiDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.
Connor R TiffanyDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.
Thaynara Parente de CarvalhoDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.
Renée M TsolisDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.ORCID 0000-0001-9131-6657
Andreas J BäumlerDepartment of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis, CA 95616.ORCID 0000-0001-9152-7809

Funding

Virulence Factors of SalmonellaR01AI044170 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BAUMLER, ANDREAS J · 1999 to 2022
$8.5M
Exacerbation of colitis by the microbiotaR01AI112445 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler · 2015 to 2026
$6.2M
Microbiota Outgrowth by SalmonellaR01AI096528 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2011 to 2025
$6.1M
Mechanism of Colonization ResistanceR01AI112949 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler · 2016 to 2026
$5.2M
Interspecies microbial interactions in CKDR01DK138912 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler, Sebastian E Winter · 2024 to 2026
$2.1M
Salmonella Host interactionsR37AI044170 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler, Renee M Tsolis · 2025 to 2026
$1.2M
Mechanism of E. coli colonization resistanceR56AI112949 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMLER, ANDREAS J · 2014 to 2014
$382k
Mechanisms of Microbial Competition During Salmonella InfectionF32AI169649 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RADLINSKI, LAUREN CHRISTINE · 2023 to 2025
$204k
HHS | National Institutes of Health (NIH) AI044170 AI096528 AI112445 AI112949 DK138912HHS | National Institutes of Health (NIH) AI169649Kenneth Rainin Foundation (KRF) 20230029NIAID NIH HHS F32 AI169649NIAID NIH HHS R01 AI044170NIAID NIH HHS R01 AI096528NIAID NIH HHS R01 AI112445NIAID NIH HHS R01 AI112949NIAID NIH HHS R37 AI044170NIAID NIH HHS R56 AI112949NIDDK NIH HHS R01 DK138912
6 · The paper itself

Abstract

The gut microbiota produces high concentrations of antimicrobial short-chain fatty acids (SCFAs) that restrict the growth of invading microorganisms. The enteric pathogen

Indexed as

Amino AcidsIleumIntestine, LargeSalmonella typhimuriumVirulence FactorsAnimalsCecumFatty Acids, VolatileGastrointestinal MicrobiomeHumansMiceSalmonella InfectionsAmino AcidsFatty Acids, VolatileVirulence Factorscolonization resistancemicrobiotaSalmonellashort-chain fatty acids

Identifiers

PMID39546570
PMCPMC11588050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.